Poly(ADP-ribose) polymerase inhibition improves postischemic myocardial function after cardioplegia-cardiopulmonary bypass (Q44533623)

3 December 2017

Poly(ADP-ribose) polymerase inhibition improves postischemic myocardial function after cardioplegia-cardiopulmonary bypass (English)

1 reference

3 December 2017

Tanveer A Khan

1

1 reference

3 December 2017

Marc Ruel

2

1 reference

3 December 2017

Cesario Bianchi

3

1 reference

3 December 2017

Pierre Voisine

4

1 reference

3 December 2017

Katalin Komjáti

5

1 reference

3 December 2017

Csaba Szabo

6

1 reference

3 December 2017

Frank W Sellke

7

1 reference

3 December 2017

1 August 2003

1 reference

Journal of the American College of Surgeons

3 December 2017

1 reference

3 December 2017

197

1 reference

3 December 2017

2

1 reference

3 December 2017

270-277

1 reference

Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

Protection by inhibition of poly (ADP-ribose) synthetase against oxidant injury in cardiac myoblasts In vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

Inhibitors of poly (ADP-ribose) synthetase protect rat cardiomyocytes against oxidant stress

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

Protection against hypoxia-reoxygenation in the absence of poly (ADP-ribose) synthetase in isolated working hearts

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

5-aminoisoquinolinone, a potent inhibitor of poly (adenosine 5'-diphosphate ribose) polymerase, reduces myocardial infarct size

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

Reduction of myocardial reperfusion injury by an inhibitor of poly (ADP-ribose) synthetase in the pig

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

Myocardial protection by PJ34, a novel potent poly (ADP-ribose) synthetase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

Adenosine-enhanced ischemic preconditioning decreases infarct in the regional ischemic sheep heart

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

Systemic free radical activation is a major event involved in myocardial oxidative stress related to cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

Peroxynitrite formation from human myocardium after ischemia-reperfusion during open heart operation

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

Monoclonal antibody to L-selectin attenuates neutrophil accumulation and protects ischemic reperfused cat myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

Platelet and neutrophil activation during cardiac surgical procedures: impact of cardiopulmonary bypass.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

Differential expression of neutrophil adhesion molecules during coronary artery surgery with cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

Leukocyte depletion attenuates reperfusion injury in patients with left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

Poly(ADP-ribose) polymerase triggers the microvascular mechanisms of hepatic ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

Leukocyte trafficking and myocardial reperfusion injury in ICAM-1/P-selectin-knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

Poly(ADP-Ribose) polymerase inhibition reduces reperfusion injury after heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

Protective effect of a novel, potent inhibitor of poly(adenosine 5'-diphosphate-ribose) synthetase in a porcine model of severe bacterial sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

Activation of poly(ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

Assessing the impact of cerebral injury after cardiac surgery: will determining the mechanism reduce this injury?

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

The therapeutic potential of poly(ADP-ribose) polymerase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900538-6

7 January 2021

10.1016/S1072-7515(03)00538-6

Identifiers

DOI

1 reference

3 December 2017

1 reference